Patents by Inventor Frederik Menges

Frederik Menges has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10759767
    Abstract: The present invention relates to compositions comprising, 1) as component I a compound of formula I, as defined in the claims and description, and 2) as component II an active ingredient, selected from the groups A) to O) defined in the claims and description.
    Type: Grant
    Filed: December 18, 2013
    Date of Patent: September 1, 2020
    Assignee: BASF AGRO B.V.
    Inventors: Jan Klaas Lohmann, Egon Haden, Dieter Strobel, Siegfried Strathmann, Martin Semar, Frederik Menges, Nadege Boudet
  • Patent number: 10512267
    Abstract: Compositions comprising a triazole compound and a biopesticide.
    Type: Grant
    Filed: June 25, 2014
    Date of Patent: December 24, 2019
    Assignee: BASF Agro, B.V.
    Inventors: Frederik Menges, Martin Semar, Nadine Riediger, Lutz Brahm, Kristin Klappach, Murat Mertoglu, Winfried Mayer, Egon Haden, Jan Klaas Lohmann, Nadege Boudet, Annette Schuster
  • Patent number: 10212934
    Abstract: The present invention relates to compositions comprising a triazole compound as component I and as a component II a compound selected from (II-1) to (II-8) and to the agrochemical compositions and the uses thereof.
    Type: Grant
    Filed: June 15, 2015
    Date of Patent: February 26, 2019
    Assignee: BASF Agro B.V.
    Inventors: Frederik Menges, Martin Semar, Lutz Brahm, Annette Schuster, Florent Mazuir
  • Patent number: 10206403
    Abstract: The present invention relates to pesticidal compositions comprising as component I a compound selected from the compounds I-1 to I-31 and as component II a compound selected from compounds II-1 to II-12.
    Type: Grant
    Filed: July 3, 2015
    Date of Patent: February 19, 2019
    Assignee: BASF SE
    Inventors: Frederik Menges, Jens Bruns, Dieter Strobel
  • Publication number: 20160150786
    Abstract: Compositions comprising a triazole compound and a biopesticide
    Type: Application
    Filed: June 25, 2014
    Publication date: June 2, 2016
    Inventors: Frederik Menges, Martin Semar, Nadine Riediger, Lutz Brahm, Kristin Klappach, Murat Mertoglu, Winfried Mayer, Egon Haden, Jan Klaas Lohmann, Nadege Boudet, Annette Schuster
  • Patent number: 9278977
    Abstract: A process for manufacturing 5-chloromethyl-2,3-pyridine dicarboxylic acid anhydrides (I) wherein Z is hydrogen or halogen; Z1 is hydrogen, halogen, cyano or nitro; comprising the steps of (i) reacting a compound of formula (II), wherein the symbols have the meaning given in formula (I), with a chlorinating agent, optionally in the presence of a radical initiator in a solvent selected from halogenated hydrocarbons, and (ii) crystallizing the compound (I) formed in step (i) from a solvent selected from chlorobenzene, 1,2-dichlorobenzene, 1,3-dichlorobenzene, 1,4-dichlorobenzene, dichloroethane, trichloromethane, dichloromethane, toluene, xylenes, ethyl acetate, methyl tert.-butyl ether, and mixtures thereof. Compounds (I) are useful intermediates in the synthesis of herbicidal imidazolinones.
    Type: Grant
    Filed: March 20, 2014
    Date of Patent: March 8, 2016
    Assignee: BASF SE
    Inventors: Frederik Menges, Joachim Gebhardt, Michael Rack, Michael Keil, Rodney F. Klima, David Cortes, Robert Leicht, Helmut Zech, Jochen Schroeder
  • Patent number: 9167817
    Abstract: The present invention relates to a process using Grignard reagents for providing thio-triazolo group-containing compounds.
    Type: Grant
    Filed: March 24, 2014
    Date of Patent: October 27, 2015
    Assignee: BASF SE
    Inventors: Maximilian Dochnahl, Michael Keil, Joachim Gebhardt, Uwe Josef Vogelbacher, Frederik Menges, Michael Rack, Jens Renner, Bernd Wolf
  • Patent number: 9096570
    Abstract: A process for manufacturing 5,6-disubstituted-3-pyridylmethyl ammonium bromides (I), wherein Q is a tertiary aliphatic or cyclic, saturated, partially unsaturated or aromatic amine; Z is hydrogen or halogen; Z1 is hydrogen, halogen, cyano or nitro; Y and Y1 are each independently OR1, NR1R2, or when taken together YY1 is —O—, —S— or NR3—; R1 and R2 are each independently hydrogen, C1-C4 alkyl optionally substituted with C1-C4 alkoxy or phenyl optionally substituted with one to three C1-C4 alkyl groups, C1-C4 alkoxy groups or halogen atoms, or phenyl optionally substituted with one to three C1-C4 alkyl groups, C1-C4 alkoxy groups or halogen atoms; R3 is hydrogen or C1-C4 alkyl; comprises the steps of (i) reacting a compound of formula (II), wherein the symbols have the meaning given in formula (I), with bromine in the presence of a radical initiator in a solvent mixture comprising an aqueous phase and an organic phase, where the organic phase comprises a solvent selected from 1,2-dichloroethane
    Type: Grant
    Filed: November 13, 2009
    Date of Patent: August 4, 2015
    Assignee: BASF SE
    Inventors: Joachim Gebhardt, Frederik Menges, Michael Rack, Michael Keil, Jochen Schroeder, Stefan Orsten, Helmut Zech, David Cortes, Robert Leicht, Tony Yegerlehner, Rodney F. Klima
  • Patent number: 9034856
    Abstract: The invention relates to 17-(1?-propenyl)-17-3?-oxidoestra-4-en-3-one derivatives with the general chemical formula I, where the residues Z, R4, R6a, R6b, R7, R15, R16a, R16b and R18 have the meanings stated in Claim 1, and their solvates, hydrates and salts, including all stereoisomers of these compounds. The invention further relates to the use of these derivatives for the production of a medicinal product for oral contraception and for the treatment of pre-, peri- and postmenopausal complaints and medicinal products that contain said derivatives, and in particular application in the aforementioned indications. The derivatives according to the invention have a progestational and in preferred cases additionally an antimineralocorticoid and neutral to slightly androgenic action.
    Type: Grant
    Filed: December 23, 2008
    Date of Patent: May 19, 2015
    Assignee: Bayer Intellectual Property GmbH
    Inventors: Ulrich Klar, Joachim Kuhnke, Rolf Bohlmann, Jan Hübner, Sven Ring, Thomas Frenzel, Frederik Menges, Steffen Borden, Hans Peter Muhn, Katja Prelle
  • Patent number: 8987239
    Abstract: The 15?,16?-methylene-17-hydroxy-19-nor-17-pregna-4-en-3-one-21-carboxylic acid ?-lactone derivatives of the present invention possess progestational efficacy. They have the general chemical formula I, in which Z is selected from the group comprising an oxygen atom, two hydrogen atoms, NOR and NNHSO2R, where R is hydrogen, C1-C10-alkyl, aryl or C7-C20-aralkyl, R4 is hydrogen or halogen, and moreover either: R6a, R6b together form methylene or 1,2-ethanediyl or R6a is hydrogen and R6b is selected from the group comprising hydrogen, C1-C10-alkyl, C2-C10-alkenyl or C2-C10-alkynyl, and R7 is selected from the group comprising hydrogen, C1-C10-alkyl, C3-C6-cycloalkyl, C2-C10-alkenyl or C2-C10-alkynyl, or: R6a is hydrogen and R6b and R7, together, denote a bond, an oxygen or form methylene, R18 represents hydrogen or C1-C3-alkyl and in addition include their solvates, hydrates, stereoisomers and salts.
    Type: Grant
    Filed: January 10, 2013
    Date of Patent: March 24, 2015
    Assignee: Bayer Intellectual Property GbmH
    Inventors: Ulrich Klar, Joachim Kuhnke, Rolf Bohlmann, Jan Hübner, Sven Ring, Thomas Frenzel, Frederik Menges, Steffen Borden, Hans-Peter Muhn, Katja Prelle
  • Patent number: 8937058
    Abstract: The invention relates to 17-hydroxy-19-nor-21-carboxylic acid-steroid ?-lactone derivatives with the chemical formula I, where R4, R6a, R6b, R7, R15, R16a, R16b, R18 and Z have the meanings stated in claim 1, and their solvates, hydrates, stereoisomers and salts. The invention further relates to the use of these derivatives for the production of a medicinal product for oral contraception and for the treatment of pre-, peri- and postmenopausal complaints and medicinal products that contain said derivatives. The derivatives according to the invention have a progestational and in preferred cases additionally an antimineralocorticoid and neutral to slightly androgenic action.
    Type: Grant
    Filed: December 23, 2008
    Date of Patent: January 20, 2015
    Inventors: Ulrich Klar, Joachim Kuhnke, Rolf Bohlmann, Jan Hübner, Sven Ring, Thomas Frenzel, Frederik Menges, Steffen Borden, Hans-Peter Muhn, Katja Prelle
  • Patent number: 8729272
    Abstract: The present invention relates to a process using Grignard reagents for providing thio-triazolo group-containing compounds.
    Type: Grant
    Filed: March 15, 2011
    Date of Patent: May 20, 2014
    Assignee: BASF SE
    Inventors: Maximilian Dochnahl, Michael Keil, Joachim Gebhardt, Uwe Josef Vogelbacher, Frederik Menges, Michael Rack, Jens Renner, Bernd Wolf
  • Patent number: 8722893
    Abstract: A process for manufacturing 5-chloromethyl-2,3-pyridine dicarboxylic acid anhydrides (I) wherein Z is hydrogen or halogen; Z1 is hydrogen, halogen, cyano or nitro; comprising the steps of (i) reacting a compound of formula (II), wherein the symbols have the meaning given in formula (I), with a chlorinating agent, optionally in the presence of a radical initiator in a solvent selected from halogenated hydrocarbons, and (ii) crystallizing the compound (I) formed in step (i) from a solvent selected from chlorobenzene, 1,2-dichlorobenzene, 1,3-dichlorobenzene, 1,4-dichlorobenzene, dichloroethane, trichloromethane, dichloromethane, toluene, xylenes, ethyl acetate, methyl tert.-butyl ether, and mixtures thereof. Compounds (I) are useful intermediates in the synthesis of herbicidal imidazolinones.
    Type: Grant
    Filed: November 3, 2009
    Date of Patent: May 13, 2014
    Assignee: BASF SE
    Inventors: Frederik Menges, Joachim Gebhardt, Michael Rack, Michael Keil, Rodney F. Klima, David Cortes, Robert Leicht, Helmut Zech, Jochen Schroeder
  • Patent number: 8716487
    Abstract: The present invention relates to a process for preparing 4-hydroxypyridines of formula I wherein R1, R2, R3 and R4 have the meanings defined in the description.
    Type: Grant
    Filed: June 20, 2011
    Date of Patent: May 6, 2014
    Assignee: BASF SE
    Inventors: Volker Maywald, Frederik Menges, Uwe Josef Vogelbacher, Michael Rack, Michael Keil, Wassilios Grammenos, Marianna Vrettou-Schultes, Jan Klaas Lohmann, Bernd Mueller, Thorsten Jabs
  • Patent number: 8629279
    Abstract: A process for manufacturing a 5-formyl-pyridine-2,3-dicarboxylic acid ester (I) wherein Z is hydrogen or halogen; Z1 is hydrogen, halogen, cyano or nitro and R1, R2 are independently C1-C10-alkyl, comprising the steps of (i) reacting a compound of formula (II), wherein the symbols are as in formula (I), with a nitrosation agent (III) R3—O—N?O (III) wherein R3 is C1-C8-alkyl, in the presence of an alkali metal or alkaline earth metal alcoholates or carbonates in a polar aprotic solvent at a temperature of from ?45 to 40° C., to obtain an oxime compound (IV) where Z, Z1, R1 and R2 are as in formula (I), and (ii) reacting oxime compound (IV) with an aliphatic C1-C10-aldehyde in the presence of a Lewis acid at a temperature in the range of from 0 to 100° C. The compounds of formula (I) are useful intermediates in the synthesis of herbicidal imidazolinones, like imazamox.
    Type: Grant
    Filed: December 7, 2009
    Date of Patent: January 14, 2014
    Assignee: BASF SE
    Inventors: Michael Rack, Joachim Gebhardt, Frederik Menges, Michael Keil, Rodney F. Klima, David Cortes, Robert Leicht, Helmut Zech, Jochen Schröder
  • Patent number: 8623850
    Abstract: The invention relates to 15,16-methylene-17-(1?-propenyl)-17-3?-oxidoestra-4-en-3-one derivatives with the general chemical formula I, where the Z, R4, R6a, R6b, R7 and R18 have the meanings stated in claim 1, and solvates, hydrates and salts thereof, including all crystal modifications and all stereoisomers of these compounds. The invention also relates to the use of these derivatives for the production of a drug for oral contraception and for the treatment of pre-, peri- and postmenopausal problems and drugs which contain such derivatives, in particular use in the aforesaid indications. The derivatives according to the invention have a progestational and in preferable cases also an antimineralcorticoid and neutral to slight androgenic activity.
    Type: Grant
    Filed: December 23, 2008
    Date of Patent: January 7, 2014
    Assignee: Bayer Intellectual Property GmbH
    Inventors: Ulrich Klar, Joachim Kuhnke, Rolf Bohlmann, Jan Hübner, Sven Ring, Thomas Frenzel, Frederik Menges, Steffen Borden, Hans-Peter Muhn, Katja Prelle
  • Patent number: 8563734
    Abstract: 2-[(1-cyanopropyl)carbamoyl]-5-chloromethyl nicotinic acids of formula (I) where Z is hydrogen or halogen; Z1 is hydrogen, halogen, cyano or nitro; R1 is C1-C4 alkyl; R2 is C1-C4 alkyl, C3-C6 cycloalkyl or R1 and R2, when taken together with the atom to which they are attached, represent a C3-C6 cycloalkyl group optionally substituted with methyl, and R3 is hydrogen or a cation preferably selected from the group consisting of alkali metals, alkaline earth metals, manganese, copper, iron, zinc, cobalt, lead, silver, nickel, ammonium and organic ammonium; are useful intermediates for the synthesis of herbicidal imidazolinones.
    Type: Grant
    Filed: November 3, 2009
    Date of Patent: October 22, 2013
    Assignee: BASF SE
    Inventors: Frederik Menges, Joachim Gebhardt, Michael Rack, Michael Keil, Rodney F. Klima, David Cortes, Robert Leicht, Helmut Zech, Jochen Schröder
  • Patent number: 8426617
    Abstract: The invention relates to the (stereoselective) hydrogenation of carbon-carbon double bonds in compounds having at least one such bond, e.g., isoprenoids, non-cyclic sesquiterpenes, tocomonoenols, tocodienols, tocotrienols or derivatives thereof, as well as to the (stereoselective) hydrogenation of parts/extracts of plant oils containing such tocotrienols or derivatives thereof, in the presence of a chiral Ir complex as the catalyst, whereby preferably one stereoisomer is manufactured in an excess.
    Type: Grant
    Filed: December 20, 2005
    Date of Patent: April 23, 2013
    Assignee: DSM IP Assets B.V.
    Inventors: Werner Bonrath, Frederik Menges, Thomas Netscher, Andreas Pfaltz, Bettina Wustenberg
  • Publication number: 20130096312
    Abstract: The present invention relates to a process for preparing 4-hydroxypyridines of formula I wherein R1, R2, R3 and R4 have the meanings defined in the description.
    Type: Application
    Filed: June 20, 2011
    Publication date: April 18, 2013
    Applicant: BASF SE
    Inventors: Volker Maywald, Frederik Menges, Uwe Josef Vogelbacher, Michael Rack, Michael Keil, Wassilios Grammenos, Marianna Vrettou-Schultes, Jan Klaas Lohmann, Bernd Mueller, Thorsten Jabs
  • Publication number: 20130005985
    Abstract: The present invention relates to a process using Grignard reagents for providing thio-triazolo group-containing compounds.
    Type: Application
    Filed: March 15, 2011
    Publication date: January 3, 2013
    Applicant: BASF SE
    Inventors: Maximilian Dochnahl, Michael Keil, Joachim Gebhardt, Uwe Josef Vogelbacher, Frederik Menges, Michael Rack, Jens Renner, Bernd Wolf